P

Inventor

BOTTONI GIUSEPPE

IT23 patents
⚠️ This page may combine multiple inventors who share the name “BOTTONI GIUSEPPE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RECORDATI CHEM PHARM

7 patents
US5472704ADec 5, 1995

Pharmaceutical controlled-release composition with bioadhesive properties

RECORDATI CHEM PHARM259 citations96
US6333044B1Dec 25, 2001

Therapeutic compositions for intranasal administration which include KETOROLAC®

RECORDATI CHEM PHARM53 citations95
US5527545AJun 18, 1996

Liquid-suspension controlled-release pharmaceutical composition

RECORDATI CHEM PHARM66 citations95
US5460828AOct 24, 1995

Process for the preparation of microgranules suitable for suspension in fluids

RECORDATI CHEM PHARM74 citations95
US5571533ANov 5, 1996

Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide

RECORDATI CHEM PHARM111 citations94
US5670171ASep 23, 1997

Liquid-suspension controlled-release pharmaceutical composition

RECORDATI CHEM PHARM30 citations92
US7267827B2Sep 11, 2007

Therapeutic compositions for intranasal administration which include KETOROLAC

RECORDATI CHEM PHARM2 citations62

UPJOHN CO

7 patents
US6087340AJul 11, 2000

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO46 citations95
US7005421B2Feb 28, 2006

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO25 citations92
US5977082ANov 2, 1999

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO30 citations92
US6107285AAug 22, 2000

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO6 citations73
US6284738B1Sep 4, 2001

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO2 citations62
US6632799B2Oct 14, 2003

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO2 citations59
US6596697B2Jul 22, 2003

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

UPJOHN CO0 citations48

ITALFARMACO SPA

2 patents
US7157099B2Jan 2, 2007

Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds

ITALFARMACO SPA127 citations93
US6984632B1Jan 10, 2006

Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives

ITALFARMACO SPA2 citations62

MAFFEI PAOLA

2 patents
US8217054B2Jul 10, 2012

Use of polyols to obtain stable polymorphous forms of rifaximin

MAFFEI PAOLA14 citations88
US8748449B2Jun 10, 2014

Use of polyols to obtain stable polymorphous forms of rifaximin

MAFFEI PAOLA5 citations80

ERBA FARMITALIA

2 patents
US5124317AJun 23, 1992

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

ERBA FARMITALIA5 citations73
US4946831AAug 7, 1990

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

ERBA FARMITALIA14 citations73

RECORDATI IRELAND LTD

1 patent
US7476689B2Jan 13, 2009

Therapeutic compositions for intranasal administration which include KETOROLAC

RECORDATI IRELAND LTD23 citations91

ERBA CARLO SPA

1 patent
US5124318AJun 23, 1992

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

ERBA CARLO SPA12 citations73

ALFASIGMA SPA

1 patent
US10280177B2May 7, 2019

Use of polyols to obtain stable polymorphous forms of rifaximin

ALFASIGMA SPA0 citations49